GEMAYEL GEORGES received a stock award from SUPERNUS PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/25/2026ACC: 0001256088-26-000004
Director
Since Feb 2026
0.00
Net shares
Net seller
$194.7K
Total acquired
0
Open market trades
0B · 0S
4
Total transactions
19.48K acquired · 19.48K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+15K
Price / share
$12.98
Trade value
$194.70K
% of position
80.3%
2/23/2026
18.68K→33.68K
Common Stock
Direct
Shares
+4.47K
Price / share
—
Trade value
—
% of position
13.3%
2/24/2026
33.68K→38.16K
Total
Net shares
+19.48K
Net value
$194.70K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/23/2026 | M · Option Exercise | +15K | $12.98 | $194.70K | 80.3% | 18.68K | 33.68K |
| Common Stock Direct | 2/24/2026 | A · Award | +4.47K | — | — | 13.3% | 33.68K | 38.16K |
| Total | +19.48K | $194.70K | ||||||
Derivative Transactions2
Director Stock Option (Right to Buy)
Direct
Converts to
Common Stock
15K shares
Shares
−15K
Strike price
12.98
Held after
0.00
Exercisable
—
2/23/2026
Restricted Stock Unit
Direct
Converts to
Common Stock
4.47K shares
Shares
−4.47K
Strike price
Held after
0.00
Exercisable
—
2/24/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Director Stock Option (Right to Buy) Direct | Common Stock15K shares | 2/23/2026 | M · Option Exercise | −15K | 12.98 | — | 0.00 |
| Restricted Stock Unit Direct | Common Stock4.47K shares | 2/24/2026 | D · Disposition | −4.47K | — | 0.00 |